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Fibroblast growth factor receptor 3 (FGFR3) trans-
duces biochemical signals via lateral dimerization in
the plasma membrane, and plays an important role
in human development and disease. Eight different
pathogenic mutations, implicated in cancers and
growth disorders, have been identified in the FGFR3
transmembrane segment. Here, we describe the
dimerization of the FGFR3 transmembrane domain
in membrane-mimicking DPC/SDS (9/1) micelles. In
thesolvedNMRstructure, the twotransmembranehe-
lices pack into a symmetric left-handed dimer, with
intermolecular stacking interactions occurring in the
dimer central region. Some pathogenic mutations fall
within the helix-helix interface, whereas others are
located within a putative alternative interface. This
implies that although the observed dimer structure is
important for FGFR3 signaling, the mechanism of
FGFR3-mediated transduction across the membrane
is complex. We propose an FGFR3 signaling mecha-
nism that is based on the solved structure, available
structures of isolated soluble FGFR domains, and
published biochemical and biophysical data.
INTRODUCTION
The four human fibroblast growth factor receptors (FGFRs)
belong to the family of receptor tyrosine kinases (RTKs) and
transduce diverse biochemical signals by lateral dimerization in
the plasma membrane, followed by receptor autophosphoryla-
tion and stimulation of downstream signaling cascades (Moham-
madi et al., 2005; Lemmon and Schlessinger, 2010). These
bitopic membrane proteins consist of an extracellular (EC)
domain with three immunoglobulin-like subdomains (D1, D2,
and D3), a single-span transmembrane (TM) domain, and a cyto-
plasmic component with tyrosine kinase activity. The kinase
domain exhibits a typical bilobal fold, consisting of an N-terminal
lobe that acts as an enzyme and a C-terminal lobe that acts as aStructure 21, 2087–20substrate (Mohammadi et al., 2005; Bae and Schlessinger,
2010). Specific ligands (fibroblast growth factors) and heparin/
heparan sulfate proteoglycans bind to the D2/D3 subdomains
of FGFR, thus stabilizing the dimeric complex and enhancing
its activity. The D1 subdomain engages in weak interactions
with the D2/D3 subdomains, which are sufficient for sustainable
autoinhibition (Mohammadi et al., 2005).
FGFRs play an important role in human growth and develop-
ment and in the adult. Mutations in these membrane proteins
result in various disorders of the connective tissues and skel-
eton. Among the family, FGFR3 is known for the largest number
of pathogenic mutations observed in human (Passos-Bueno
et al., 1999; Li and Hristova, 2006). The most frequent patho-
genic mutations G380R and A391E in the TM region of FGFR3
are associated both with cancer and with disorders in skeletal
development, causing achondroplasia and Crouzon syndrome
with acanthosis nigricans, respectively. The exact mechanism
of FGFR3-mediated signal transduction in health and disease
is unknown, and likely will not emerge until high-resolution struc-
tures of full-length wild-type and mutant FGFR3 dimers in
various stages of their activation become available. Although
obtaining structures of full-size RTK proteins is still not feasible,
isolated soluble RTK domains have been produced and studied.
In particular, crystal structures have been obtained for the EC
ligand-binding domains as well as for the kinase domains of
FGFRs in different functional states (Bae and Schlessinger,
2010; Mohammadi et al., 2005). To complete the picture, in the
present paper, we describe the high-resolution NMR structure
of thehumanFGFR3TMdomaindimer in amembrane-mimicking
environment consisting of mixed d38-dodecylphosphocholine/
d29-sodium dodecylsulfate (DPC/SDS) (9/1) micelles. The ob-
tained structural-dynamic information along with the available
biophysical and biochemical data provides useful insights into
FGFR3 function at the molecular level.
RESULTS
The FGFR3 TM Helix Undergoes a SlowMonomer-Dimer
Transition in the Micellar Environment and Elongates
upon Dimer Formation
In order to investigate the structural and dynamic behavior
of the TM domain of FGFR3, we prepared a recombinant93, November 5, 2013 ª2013 Elsevier Ltd All rights reserved 2087
Figure 1. NMR Spectra of FGFR3tm in aMembrane-Mimicking Envi-
ronment
(A and B) Heteronuclear 1H/15N-TROSY NMR spectra of FGFR3tm in mixed
DPC/SDS (9/1) micelles at a D/P of 140 (A) and 65 (B), 40S, and rO 5.7 are
shown. The 1H-15N backbone and side-chain resonance assignments are
shown. The TM region 367–399 undergoes a slow monomer-dimer transition,
as proved by the comparison of the 1H/15N-TROSY (appearance of signal
doubling) and 15N,13C-F1-filtered/F3-edited-NOESY (registration of inter-
monomeric NOE) spectra acquired at a D/P of 140 and 65.
(C) Generalized chemical shift changes,Dd(1H15N)dm, for the FGFR3tm amide
groups are calculated as the geometrical distance (with weighting of 1H shifts
by a factor of 5 compared to 15N shifts) between the amide cross-peaks as-
signed to the dimeric and monomeric FGFR3tm states in the 1H/15N-TROSY
spectrum acquired at a D/P of 65. The measurement of uncertainty is shown in
the upper right corner. Bottom: pattern of unambiguous intermonomeric NOE
connectivities (shown with solid and dashed lines), identified between the
subunits (underlined) of the symmetric FGFR3tm dimer.
See also Figures S1–S3 and Table S1.
Structure
Structure of FGFR3 Transmembrane Domain Dimer43-residue fragment, FGFR3357–399 (named FGFR3tm), which
includes the TM domain (residues Val372–Leu398) and the
EC juxtamembrane (JM) region (residues Ala359–Ser371
between the EC and TM domains). The self-association and
monomer-dimer transition were detected for FGFR3tm
embedded in mixed DPC/SDS (9/1) micelles at detergent/
peptide molar ratios (D/Ps) lower than 120 (Figure 1; see also
Figure S1A available online). This was confirmed by the
analysis of a 15N,13C-F1-filtered/F3-edited-NOESY spectrum
acquired at a D/P of 65 that reveals the characteristic nuclear
Overhauser effect (NOE) connectivities for a dimeric structure
of FGFR3tm (Figure 1C; see also Table S1 and Figure S2). As
the minimal distinguishable chemical shift difference between
signals of two states in the 1H/15N-TROSY spectrum is
20 Hz, the monomer-dimer transition is a slow process (on
the millisecond timescale or slower), with an occupancy of
the states and apparent free energy of association DGapp
dependent on D/P (Figure S1). At lower D/P values, the dimer
population increases rapidly, but this is accompanied by
the appearance of an additional broad satellite signal near
some amide cross-peaks in the NMR spectra (Figure 1B),
indicative of higher-order oligomerization, followed by sample
precipitation.
Because only one set of signals can be seen in the NMR
spectra for FGFR3tm in the dimeric state, the dimer is symmet-
rical on the NMR timescale (in the millisecond range). Therefore,
the distance and torsion angle restraints identified for FGFR3tm
were symmetrized in order to obtain the dimer spatial structure
(Table 1 and Figure 2A; see also Figure S4). The relatively long
(43 A˚) TM helix of the FGFR3tm dimer subunit consists of a
water-exposed N-terminal turn 369–371 followed by stable
310- and a-helical TM regions 372–378 and 379–398, respec-
tively (Figure 2B; see also Figures S3–S5). In the helical regions,
besides backbone hydrogen bonding, the side-chain hydroxyl
PgO groups of Ser378 and Thr394 form (according to the local
NOE pattern) intramolecular hydrogen bonds with the back-
bone carbonyl groups of Gly375 and Val390, respectively (Fig-
ure S6). The similar chemical shifts of 1H, 13C, and 15N nuclei
for monomeric and dimeric forms of FGFR3tm indicate that
the overall structure of the dimer subunits does not undergo
significant changes upon helix-helix interaction. Nevertheless,
in the monomeric state, the N-terminal turn 369–372 of the
TM helix is flexible and unfolded, whereas its conformation is
stabilized upon dimerization, as revealed by the appearance
of intra- (i, i+3) and intermonomeric NOE connectivities with
Ala369 (Figure 1C; see also Figure S7). Indeed, observed posi-
tive values of the differences between dimeric and monomeric
1HN chemical shifts in this region (Figure S4F) indicate a
hydrogen-bond formation (or stabilization) of the amide groups
of Val372 and Tyr373 with adjacent potential acceptor groups
(backbone carbonyl groups of Glu368, Ala369, or Gly370). More-
over, in the dimeric state, the short 310-helical region also
becomes more rigid and/or changes its orientation relative to
the a-helical part, which is reflected in a more pronounced
rise, as compared to the C-terminal residues, in the local effec-
tive rotation correlation times tR along this region upon dimer-
ization (Figure S4F). At the same time, the water-exposed
and negatively charged N-terminal JM region 357–368 remains
highly flexible.2088 Structure 21, 2087–2093, November 5, 2013 ª2013 Elsevier Ltd All rights reserved
Table 1. Structural Statistics for the Ensemble of 25 NMR
Structures of the FGFR3tm Dimer, Protein Data Bank ID Code
2LZL
NMR Distance and Dihedral Restraints
Total unambiguous NOE restraints 586
Intraresidue 226
Interresidue 334
Sequential (ji  jj = 1) 174
Medium-range (1 < ji  jj% 4) 160
Long-range (ji  jj > 4) 0
Intermonomeric NOE 26
Hydrogen-bond restraints (upper/lower)
19 3 2 backbone to backbone 114/114
2 3 2 side chain to backbone 8/8
Total torsion angle restraints 154
Backbone 4 52
Backbone c 52
Side-chain c1 42
Side-chain c2 10
Structure Calculation Statistics
CYANA target function (A˚2) 1.5 ± 0.1
Restraint violations
Distance (>0.2 A˚, >0.25 A˚) 2, 0
Dihedral (>5, >6) 2, 0
Average pairwise root-mean-square deviation (A˚)
Stable TN helix region (373–398)2
Backbone atoms 0.24 ± 0.10
All heavy atoms 0.78 ± 0.14
TN helix region (369–398)2
Backbone atoms 0.27 ± 0.12
All heavy atoms 0.73 ± 0.18
Ramachandran analysis
Residues in most favored regions (%) 91.7
Residues in additional allowed regions (%) 8.2
Residues in generously allowed regions (%) 0.1
Residues in disallowed regions (%) 0.0
Helix-helix packing
Contact surface area per dimer subunit (A˚2) 870 ± 40
Angle q between the TM helix axes () 23 ± 2
Distance d between the TM helix axes (A˚) 8.6 ± 0.4
See also Figure S4 and 3D Molecular Model S1.
Structure
Structure of FGFR3 Transmembrane Domain DimerThe Association Mode of FGFR3 TM Helices Is Mediated
by a Left-Handed Symmetric Dimer via an Elongated
Heptad Motif
In the micellar environment, the FGFR3tm TM helices (Ala369–
Leu398)2 associate in a parallel fashion in a left-handed dimer
via an extended heptad (Moore et al., 2008) motif
YA374X2L
377X2G
380X2FF
384X2IL
388X2A
391X2TL
395 with a distance
d between the helix axes of 8.6 A˚ and a helix-helix crossing angle
q of 23 (Figures 2B and 2C). Along the heptadmotif, a packing in
the ‘‘knobs-into-holes’’ manner is mediated by van der Waals
contacts of the large hydrophobic side chains of valine, isoleu-Structure 21, 2087–20cine, and leucine residues, which are abundant on the large
helix-helix contact surface extending over 870 A˚2. In the N-termi-
nal part of the FGFR3tm dimer, the aromatic rings of opposite
Tyr373 residues act, most likely, as anchors positioning the TM
domain in the detergent head group region. The tight helix-helix
packing in the central region of the FGFR3tm dimer is supported
by intra- and intermonomeric stacking p-p interactions of resi-
dues (Y379-FF384-F386)2 forming an aromatic ring patch. The aro-
matic ring of Phe384 from one dimer subunit intercalates like a
clasp between the rings of Tyr379 and Phe383 (involved in multiple
intermonomeric NOE contacts) of the second subunit. Indeed,
the resonance broadening related to intermediate exchange pro-
cesses (which occur with dimerization and are pronounced for
the aromatic rings; Figure S8) can be attributed, at least partially,
to a change in mobility of the intercalating rings due to restriction
of their flip-flop rotation (Wagner et al., 1976). In addition, weak
polar intermonomeric interactions between the Phe384 aromatic
rings and the backbone atoms of the opposite Gly380 residues
located near the point of closest helix approach also occur, sup-
porting the observation that the dimerization is enhanced by the
proximity of phenylalanine and glycine residues (Unterreitmeier
et al., 2007). Thus, the FGFR3tm dimer is stabilized by multiple
van der Waals and p-p contacts as well as weak electrostatic in-
teractions. On the other hand, the charged residues flanking the
TM helix on both termini have an apparently profound destabiliz-
ing effect on the dimer. As was shown recently, FGFR3 TM helix
association can be drastically amplified by amino acid substitu-
tions in the C-terminal Arg patch (CRLR399) (Peng et al., 2009). It
should be noted that the standard free energy DGo (Fleming,
2002) of FGFR3 TM helix association is rather small in the used
micellar environment (1.3 kcal/mol; see Figure S1B) as well
as in lipid bilayers (about 3 kcal/mol), which is typical for RTK
TM domains (Li and Hristova, 2010; Bocharov et al., 2012).
Significantly, such weak interactions may be critical for FGFR3
signaling, allowing the propagation of conformational changes
in the dimer upon ligand binding.
DISCUSSION
A Mechanistic Model of FGFR3 Signaling
It has been proposed that ligand binding increases FGFR activa-
tion by stabilizing the receptor dimer and/or altering the
preformed dimer structure (Belov and Mohammadi, 2012). Unli-
ganded FGFR dimers are phosphorylated to a small degree,
which is often referred to as the ‘‘basal’’ phosphorylation level;
this results in basal ‘‘noise’’ activity. Upon ligand binding, the
FGFR dimer moves into a state with a higher phosphorylation
level and full activity. The dimeric adaptor protein Grb2 can
inhibit the basal activity of FGFR (and, seemingly, of other
RTKs) by means of entrapping the otherwise mobile kinase
domain C termini of the preformed receptor dimer in a partially
phosphorylated state (when only tyrosines in the activation
loop are phosphorylated), allowing rapid response to ligand
stimulation (Belov and Mohammadi, 2012; Lin et al., 2012).
Here, we present a spatial structure of the FGFR3 TM domain
dimer in a membrane-mimicking environment. There is also a
high-resolution structure of the monomeric EC domain of
FGFR3 in the presence of a ligand (Mohammadi et al., 2005).
However, no high-resolution structures of the FGFR3 kinase93, November 5, 2013 ª2013 Elsevier Ltd All rights reserved 2089
Figure 2. Spatial Structure of the FGFR3tm Dimer
(A) The 25 NMR structures of the FGFR3tm dimer are superimposed on
backbone atoms of the TMhelical regions (Tyr373–Leu398)2. Heavy-atombonds
are shown only and painted in black and magenta for different dimer subunits.
(B) Ribbon structure of the FGFR3tm dimer. Negatively charged, positively
charged, aromatic, large hydrophobic, and small side chains are shown in red,
blue, cyan, light yellow, and green, respectively. The approximate position of
the membrane borders is highlighted by the yellow stripes. Pathogenic
mutations are indicated by arrows.
(C) Properties of the FGFR3tm dimer interface. Left: hydrophobic and hydro-
philic (polar) surfaces of the TM helix subunit are colored in yellow and green,
Structure
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2090 Structure 21, 2087–2093, November 5, 2013 ª2013 Elsevier Ltddomain are available to date. On the other hand, the monomeric
and dimeric structures of the EC and kinase domains have been
described for different functional states of FGFR1 and FGFR2, as
well as of receptors from other RTK families (Bae and Schles-
singer, 2010; Mohammadi et al., 2005). As there are no struc-
tures of full-length RTKs, we do not fully understand how
different domains function together to mediate signal transduc-
tion inside the cell. Nevertheless, the available structures of
isolated RTK domains have already greatly enhanced our under-
standing of RTK signaling.
Recent work has suggested that the asymmetry of RTK kinase
domain dimers is likely a critical determinant of their activity. The
discoveries that (1) EGFR kinases are activated allosterically
upon the formation of asymmetric kinase dimers and that (2)
inactive EGFR kinase dimers are likely symmetric have spurred
investigations of the role of structural asymmetry in the activation
of other RTKs (Lemmon and Schlessinger, 2010; Jura et al.,
2009; Landau and Ben-Tal, 2008). The kinase domains of
FGFR also form an asymmetric dimer during receptor activation,
whereas the symmetric kinase dimer is attributed to an autoinhi-
bited conformation (Mohammadi et al., 1996; Bae and Schles-
singer, 2010). Asymmetric kinase domain dimers have been
reported for FGFR1 and FGFR2, with structures that are
distinctly different from the structure of the asymmetric EGFR
kinase domain dimer (Bae and Schlessinger, 2010). This is not
surprising, as FGFR kinases are activated via cross-phosphory-
lation of tyrosines on the activation loop, and not allosterically
like EGFR (Lemmon and Schlessinger, 2010). Yet, the very dis-
covery of FGFR kinase domain asymmetric dimers suggests
that the role of symmetry in activation control may be similar
throughout the RTK family. By analogy with EGFR, it can be
hypothesized that the asymmetric FGFR kinase dimers are fully
active and that symmetric kinase dimers exist in the basal phos-
phorylation state. If two distinct FGFR3 dimeric structures exist,
does the solved TM dimer structure correspond to the basal
phosphorylation state or to the high-activity state? For the
EGFR dimers, it has been argued that the C termini of the TM
domains need to be spaced apart (by about 20 A˚) in order for
the asymmetric kinase dimer configuration to be achieved
(Jura et al., 2009). As the helices in the observed FGFR3 TM
structure are packed via an extended heptad motif with a small
crossing angle between the helices, the C termini are very close
and, therefore, one can hypothesize that the structure corre-
sponds to the basal phosphorylation state.
On the other hand, an extended concavity covers the
N-terminal half of the FGFR3 TM helix, with Gly, Ser, and Alarespectively. The complementary subunit is shown in a stick representation.
Right: hydrophobicity map of the molecular surface of the TM helix, with the
isolines encircling hydrophobic regions with high molecular hydrophobicity
potential (MHP) values. The map, constructed as described in Supplemental
Experimental Procedures, is presented in cylindrical coordinates associated
with the TM helix. The observed helix-packing interface of FGFR3tm is indi-
cated with magenta dots. An alternative dimerization interface, rich in
consensus helix-packing GG4-like motifs, is encircled by the light green oval.
Significantly, similar dimerization interfaces were predicted for the FGFR3 TM
domain by molecular modeling (Li et al., 2006; Volynsky et al., 2013). Residues
that harbor pathogenic mutations (Li and Hristova, 2006) are highlighted in
yellow with amino acid substitutions marked additionally in red.
See also Table S1, Figures S2, S5–S8, and S10, and 3D Molecular Model S1.
All rights reserved
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Structure of FGFR3 Transmembrane Domain Dimerresidues creating a weakly polar surface outside of the ob-
served dimerization interface (Figure 2C). These residues with
small side chains are parts of small-X3-small tetrad motifs
G370X3A
374X3S
378X3G
382 and S371X3G
375. These so-called
GG4-like motifs have been shown to mediate dimerization in
many membrane proteins, including RTKs (Moore et al., 2008;
Bocharov et al., 2008, 2010a). It is therefore possible that an
alternative FGFR3 TM dimer structure, employing the GG4-like
motifs, exists. Such a putative structure can be expected to
have a helix-helix crossing angle near 40 (Moore et al., 2008;
Bocharov et al., 2010a), and can be obtained from the experi-
mentally observed conformation through rotation of the TM heli-
ces around their axes followed by a helix-helix crossing angle
increase. As the site of the expected contact is close to the N
terminus and the crossing angle is large, the C termini of the
TM helices will be more spaced in this dimer structure than in
the observed dimerization mode. We can thus hypothesize that
this alternative dimerization mode via the N-terminal GG4-
like motifs (Figure 2C) corresponds to the fully active FGFR3
state (similar to the EGFR kinase activation model; Jura et al.,
2009).
The conformation of the unliganded RTK EC domains likely
prevents the transition to the fully active dimer state (Endres
et al., 2013). Indeed, the FGFR3 EC domain has been found to
inhibit dimerization (by 1 kcal/mol) in the absence of ligand,
whereas the TM domain interaction has been shown to stabilize
the FGFR3 dimer (by4 kcal/mol) (Li and Hristova, 2010; Chen
et al., 2010). Based on the above arguments, we propose that the
FGFR3 unliganded dimer is stabilized by the heptad motif con-
tacts shown in Figure 2C, in addition to possible stabilization
due to kinase domain and Grb2 interactions. Upon ligand bind-
ing, there are conformational changes in the FGFR3 EC domains
that stabilize the EC domain dimer. The liganded FGFR3
EC domain dimer likely adopts the symmetric conformation
observed in the crystal structures of the isolated FGFR1 D2/D3
subdomains in the presence of FGF and heparin (Mohammadi
et al., 2005). We propose that upon ligand binding, the full-length
FGFR3 dimer undergoes a further conformational transition, in
the course of which the TM domain dimer switches into the alter-
native structure mediated by the N-terminal GG4-like motifs. As
there is a ‘‘hard linkage’’ between the TM domain and the kinase
domain (Bell et al., 2000), the rearrangements within the TM
dimer, which increase the distance between the TM domain C
termini, likely allow for the transition to the asymmetric fully
active kinase conformation.
Whatmechanism can underlie the TMdimer interface switch in
response to ligand binding? Remarkably, according to the crys-
tal structures, the C termini of the ligand-bound EC domains in
the activated FGFR dimer are spaced apart by at least 50 A˚
(Mohammadi et al., 2005). On the other hand, the flexible extra-
cellular JM regions (about ten residues each, with a total length
of 30 A˚ in the fully extended conformation) have to bridge the
C termini of the EC domains and the N termini of the TM helices,
which are close to each other in both dimerization modes. So,
ligand binding to the preformed FGFR dimer would cause
unwinding of the extracellular JM regions, creating tension in
the receptor structure. In order to meet these restraints, changes
of the secondary structure of each TM helix (e.g., unfolding of the
N-terminal turn A369GSV372), as well as rotational rearrange-Structure 21, 2087–20ments of the TM dimer subunits with respect to each other, are
likely required, thus inducing transition to the alternative dimer-
ization mode. The increase of the helix-helix crossing angle
resulting in a large separation between the S termini of the TM
helices would provide adequate space for proper asymmetric
orientation of the kinase domains, followed by Grb2 release
allowing further receptor autophosphorylation and downstream
signaling cascades. Thus, the kinase domains follow the struc-
tural rotational rearrangements of the TM helices, as has been
demonstrated for the Neu and EGF receptors (Bell et al., 2000;
Moriki et al., 2001). This mechanism is reminiscent of the move-
ment of a marionette controlled by a puppeteer using strings
(Figure 3). The ligand plays the role of the puppeteer and the
short JM segments connecting the EC domains and TM helices
behave as the strings, rotating the TM helices and providing the
space required for an asymmetric disposition of the two kinase
domains. Ligand binding has long been believed to stabilize
the FGFR dimeric state, and even induce dimerization. In the
model that we propose here, the role of the ligand is to create
tension in the EC domains and thus destabilize the symmetric
kinase dimer, resulting in a transition to the asymmetric active
kinase conformation.
FGFR3 TM Domain Dimerization Alternatives and
Pathogenic Mutations
The essential and diverse roles of RTKs are evident from the
various developmental abnormalities and cancers that occur
due to gain-of-function RTK signaling (Li and Hristova, 2006).
Many of these mutations are believed to increase the population
of fully active dimers in the plasma membrane (He and Hristova,
2012). Other consequences of the mutations may include pro-
cessing defects, such as impeded trafficking and defective
downregulation (Cho et al., 2004; Bonaventure et al., 2007). A
number of inherited skeletal malformations and cancers are
caused by point mutations in the FGFR3 TM domain (Li and Hris-
tova, 2006). The right panel of Figure 2C (see also Figure S10 and
Table S2) shows themapping of known pathogenicmutations on
the surface of the FGFR3 TM helix. Obviously, some pathogenic
mutations, including themost common substitutions G380R and
A391E causing achondroplasia and Crouzon syndrome, fall
within the observed TM helix-helix interface. This finding implies
that the obtained TM dimer conformation is important for recep-
tor functioning (at least for stabilizing the FGFR3 dimer in its
basal phosphorylation state). Nevertheless, it would be difficult
to envision that a single TM dimer structure can explain how all
these mutations affect FGFR3 dimer structure and activity. The
hypothesis that the FGFR3 TM domain can form two alternative
dimers, corresponding to the fully active and the basal phos-
phorylation states of the receptor, can provide the basis for
such an explanation. In general, pathogenic mutations in the
TM domain can either stabilize the fully active receptor confor-
mation (e.g., by intermolecular hydrogen or S-S bonding) or
destabilize the basal phosphorylation conformation (e.g., by
imposing steric clashes or due to intramembrane Coulomb
repulsion of charged side chains) and thus force the receptor
into the fully active state (for a more detailed discussion, see
Supplemental Discussion ‘‘Mechanistic Insights into the
Effects of TM Pathogenic Mutations on FGFR3 Helix-Helix Inter-
actions’’ and Figure S11). This simple mechanistic interpretation93, November 5, 2013 ª2013 Elsevier Ltd All rights reserved 2091
Figure 3. ‘‘String-Puppet’’ Mechanism of FGFR3 Activation under
the Assumption that Two Alternative Dimer Structures Exist in the
Presence and Absence of Ligand
(A) Left: the FGFR3 TM domain dimer is formed via the heptad motif shown in
Figure 2. The small TM helix-helix crossing angle keeps the receptor cyto-
plasmic domains in a symmetric configuration, resulting in a basal phos-
phorylation state, which is stabilized by the homodimeric adaptor protein
Grb2. The autophosphorylation sites are schematically presented by open
and filled orange circles. The disposition of the EC domains in the unliganded
FGFR3 dimer is not known. Right: FGFR3 activation requires asymmetric
configuration of the kinase domains, which is easier to achieve when the
C termini of the TM FGFR3 domains are spaced apart (by 20 A˚). This
configuration corresponds to an alternative dimerization mode of the TM
domain, utilizing the N-terminal tetrad GG4-like motif. Ligand binding (FGF
and heparin/heparan) induces a conformational change in the EC domain and
pushes the D3 subdomains (i.e., the C termini of the EC domains) away from
each other (by 50 A˚). This structural change imposes spatial restraints via
the short extracellular JM regions (‘‘strings’’) on the configuration of the entire
receptor dimer, inducing motions in the receptor dimer, Grb2 release, and
receptor activation. The TM domain dimer switches into the high crossing
angle structure, and the kinase domains adopt the fully active asymmetric
configuration.
(B) Schematic top view of the FGFR3 TM domain dimer in its putative basal
phosphorylation (left) and fully active (right) conformations mediated by the
heptad and tetrad motifs, respectively. Analogous TM helix-packing diversity
was recently observed for other RTKs (Bocharov et al., 2010b); see also Fig-
ure S9. Ligand binding followed by structural rearrangements of the EC do-
mains and extension of the extracellular JM regions likely induces unfolding of
the N-terminal turn A369GSV372 and rotational movements of the TM helices,
which increases the distance between their C termini and allows for the for-
mation of the asymmetric kinase dimer.
See also Figure S9.
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Structure of FGFR3 Transmembrane Domain Dimercan explain many experimental observations, but has to be
confirmed by structural studies of the corresponding pathogenic
mutants. Finally, it should be kept in mind that other membrane
proteins and the membrane environment can modulate the ef-
fect of the mutations and contribute to the diverse pathological
phenotypes.2092 Structure 21, 2087–2093, November 5, 2013 ª2013 Elsevier LtdEXPERIMENTAL PROCEDURES
The 15N- and 15N/13S-labeled and unlabeled samples of the recombinant
peptide FGFR3tm (L357PAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLC
RLR399; the hydrophobic TM segment is underlined) were produced in
Escherichia coli and solubilized in an aqueous suspension of mixed DPC/
SDS (9/1, mol/mol) micelles at rO 5.7 according to Goncharuk et al. (2011).
Two NMR samples of FGFR3tm were prepared: a uniformly 15N-labeled
sample and a 1/1 mixture of unlabeled and 15N/13S-labeled peptide (referred
to as an ‘‘isotopic heterodimer’’ sample). The self-association of FGFR3tm
was studied while varying the detergent/peptide molar ratio within the
range of 30–520. For the dimeric FGFR3tm structure determination, the
concentrations of the 15N-labeled and isotopic heterodimer samples were
1.0 and 1.5 mM, respectively, at a D/P of 65. NMR spectra were acquired at
40C on 600 and 800 MHz AVANCE III spectrometers (Bruker BioSpin) equip-
ped with pulsed-field gradient triple-resonance cryoprobes. 1H, 13C, and 15N
resonances of FGFR3tm were assigned with CARA software (Keller, 2004)
using two- and three-dimensional heteronuclear experiments (Cavanagh
et al., 2006): 1H/15N-HSQC, 1H/15N-TROSY, 1H/13C-HSQC, 1H/15N-HNHA,
1H/15N-HNHB, 1H/13C/15N-HNCA, 1H/13C/15N-HN(CO)CA, 1H/13C/15N-
HNCO, 1H/13S-HSCH-TOCSY, and 13C- and 15N-edited NOESY-HSQC/
TROSY. The intra- and intermonomeric NOE distance restraints were derived
through the analysis of three-dimensional 15N- and 13C-edited NOESY and
15N,13C-F1-filtered/F3-edited-NOESY spectra (Stuart et al., 1999) acquired
for the isotopic heterodimer FGFR3tm sample. The spatial structure of the
FGFR3tm dimer was calculated with the CYANA program (Gu¨ntert, 2003)
based on proton-proton NOE connectivities and torsion angle restraints
(Berjanskii et al., 2006). Detailed experimental procedures of sample prepara-
tion and spatial structure calculation are described in Supplemental Experi-
mental Procedures.
ACCESSION NUMBERS
The atomic coordinates and structure factors of the FGFR3tmdimer have been
deposited in the Protein Data Bank (http://www.rcsb.org) under ID code 2LZL.
The chemical shift assignments have been deposited in the Biological
Magnetic Resonance Data Bank (http://www.bmrb.wisc.edu) under ID code
18763.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Discussion, Supplemental
Experimental Procedures, 11 figures, and 2 tables, and can be found with
this article online at http://dx.doi.org/10.1016/j.str.2013.08.026.
ACKNOWLEDGMENTS
The authors express their sincere thanks to Drs. P.E. Volynsky and K.V. Pavlov
for helpful discussions. This work was supported by the Russian Academy of
Sciences Program ‘‘Molecular and Cellular Biology,’’ Russian Foundation for
Basic Research (12-04-01816-a and 14-04-31947 mol_a) and National Insti-
tutes of Health (GM068619) grants. E.V.B. personally thanks K.A. Beirit
(‘‘Russian Funds’’ Investment Group) for financial support.
Received: June 16, 2013
Revised: August 28, 2013
Accepted: August 30, 2013
Published: October 10, 2013
REFERENCES
Bae, J.H., and Schlessinger, J. (2010). Asymmetric tyrosine kinase arrange-
ments in activation or autophosphorylation of receptor tyrosine kinases. Mol.
Cells 29, 443–448.
Bell, C.A., Tynan, J.A., Hart, K.C., Meyer, A.N., Robertson, S.C., and
Donoghue, D.J. (2000). Rotational coupling of the transmembrane and kinase
domains of the Neu receptor tyrosine kinase. Mol. Biol. Cell 11, 3589–3599.All rights reserved
Structure
Structure of FGFR3 Transmembrane Domain DimerBelov, A.A., and Mohammadi, M. (2012). Grb2, a double-edged sword of
receptor tyrosine kinase signaling. Sci. Signal. 5, pe49.
Berjanskii, M.V., Neal, S., and Wishart, D.S. (2006). PREDITOR: a web server
for predicting protein torsion angle restraints. Nucleic Acids Res. 34(Web
Server issue), W63–W69.
Bocharov, E.V., Mineev, K.S., Volynsky, P.E., Ermolyuk, Y.S., Tkach, E.N.,
Sobol, A.G., Chupin, V.V., Kirpichnikov, M.P., Efremov, R.G., and Arseniev,
A.S. (2008). Spatial structure of the dimeric transmembrane domain of the
growth factor receptor ErbB2 presumably corresponding to the receptor
active state. J. Biol. Chem. 283, 6950–6956.
Bocharov, E.V., Volynsky, P.E., Pavlov, K.V., Efremov, R.G., and Arseniev, A.S.
(2010a). Structure elucidation of dimeric transmembrane domains of bitopic
proteins. Cell Adhes. Migr. 4, 284–298.
Bocharov, E.V., Mayzel, M.L., Volynsky, P.E., Mineev, K.S., Tkach, E.N.,
Ermolyuk, Y.S., Schulga, A.A., Efremov, R.G., and Arseniev, A.S. (2010b).
Left-handed dimer of EphA2 transmembrane domain: helix packing diversity
among receptor tyrosine kinases. Biophys. J. 98, 881–889.
Bocharov, E.V., Mineev, K.S., Goncharuk, M.V., and Arseniev, A.S. (2012).
Structural and thermodynamic insight into the process of ‘‘weak’’ dimerization
of the ErbB4 transmembrane domain by solution NMR. Biochim. Biophys.
Acta 1818, 2158–2170.
Bonaventure, J., Horne, W.C., and Baron, R. (2007). The localization of FGFR3
mutations causing thanatophoric dysplasia type I differentially affects phos-
phorylation, processing and ubiquitylation of the receptor. FEBS J. 274,
3078–3093.
Cavanagh, J., Fairbrother,W.J., Palmer, A.G., and Skelton, N.J. (2006). Protein
NMR Spectroscopy: Principles and Practice, Second Edition. (San Diego:
Academic Press).
Chen, L., Placone, J., Novicky, L., and Hristova, K. (2010). The extracellular
domain of fibroblast growth factor receptor 3 inhibits ligand-independent
dimerization. Sci. Signal. 3, ra86.
Cho, J.Y., Guo, C., Torello, M., Lunstrum,G.P., Iwata, T., Deng, C., andHorton,
W.A. (2004). Defective lysosomal targeting of activated fibroblast growth fac-
tor receptor 3 in achondroplasia. Proc. Natl. Acad. Sci. USA 101, 609–614.
Endres, N.F., Das, R., Smith, A.W., Arkhipov, A., Kovacs, E., Huang, Y., Pelton,
J.G., Shan, Y., Shaw, D.E., Wemmer, D.E., et al. (2013). Conformational
coupling across the plasma membrane in activation of the EGF receptor.
Cell 152, 543–556.
Fleming, K.G. (2002). Standardizing the free energy change of transmembrane
helix-helix interactions. J. Mol. Biol. 323, 563–571.
Goncharuk, S.A., Goncharuk, M.V., Mayzel, M.L., Lesovoy, D.M., Chupin, V.V.,
Bocharov, E.V., Arseniev, A.S., and Kirpichnikov, M.P. (2011). Bacterial syn-
thesis and purification of normal and mutant forms of human FGFR3 trans-
membrane segment. Acta Naturae 3, 77–84.
Gu¨ntert, P. (2003). Automated NMR protein structure calculation. Prog. Nucl.
Magn. Reson. Spectrosc. 43, 105–125.
He, L., and Hristova, K. (2012). Physical-chemical principles underlying RTK
activation, and their implications for human disease. Biochim. Biophys. Acta
1818, 995–1005.
Jura, N., Endres, N.F., Engel, K., Deindl, S., Das, R., Lamers, M.H., Wemmer,
D.E., Zhang, X., and Kuriyan, J. (2009). Mechanism for activation of the EGFStructure 21, 2087–20receptor catalytic domain by the juxtamembrane segment. Cell 137, 1293–
1307.
Keller, R.L.J. (2004). The Computer Aided Resonance Assignment Tutorial.
(Goldau, Switzerland: CANTINA Verlag).
Landau, M., and Ben-Tal, N. (2008). Dynamic equilibrium between multiple
active and inactive conformations explains regulation and oncogenic muta-
tions in ErbB receptors. Biochim. Biophys. Acta 1785, 12–31.
Lemmon, M.A., and Schlessinger, J. (2010). Cell signaling by receptor tyrosine
kinases. Cell 141, 1117–1134.
Li, E., and Hristova, K. (2006). Role of receptor tyrosine kinase transmembrane
domains in cell signaling and human pathologies. Biochemistry 45, 6241–
6251.
Li, E., and Hristova, K. (2010). Receptor tyrosine kinase transmembrane
domains: function, dimer structure and dimerization energetics. Cell Adhes.
Migr. 4, 249–254.
Li, E., You, M., and Hristova, K. (2006). FGFR3 dimer stabilization due to a
single amino acid pathogenic mutation. J. Mol. Biol. 356, 600–612.
Lin, C.C., Melo, F.A., Ghosh, R., Suen, K.M., Stagg, L.J., Kirkpatrick, J., Arold,
S.T., Ahmed, Z., and Ladbury, J.E. (2012). Inhibition of basal FGF receptor
signaling by dimeric Grb2. Cell 149, 1514–1524.
Mohammadi, M., Schlessinger, J., and Hubbard, S.R. (1996). Structure of the
FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mecha-
nism. Cell 86, 577–587.
Mohammadi, M., Olsen, S.K., and Ibrahimi, O.A. (2005). Structural basis for
fibroblast growth factor receptor activation. Cytokine Growth Factor Rev.
16, 107–137.
Moore, D.T., Berger, B.W., and DeGrado, W.F. (2008). Protein-protein interac-
tions in the membrane: sequence, structural, and biological motifs. Structure
16, 991–1001.
Moriki, T., Maruyama, H., and Maruyama, I.N. (2001). Activation of preformed
EGF receptor dimers by ligand-induced rotation of the transmembrane
domain. J. Mol. Biol. 311, 1011–1026.
Passos-Bueno, M.R., Wilcox, W.R., Jabs, E.W., Sertie´, A.L., Alonso, L.G., and
Kitoh, H. (1999). Clinical spectrum of fibroblast growth factor receptor muta-
tions. Hum. Mutat. 14, 115–125.
Peng, W.C., Lin, X., and Torres, J. (2009). The strong dimerization of the trans-
membrane domain of the fibroblast growth factor receptor (FGFR) is modu-
lated by C-terminal juxtamembrane residues. Protein Sci. 18, 450–459.
Stuart, A.C., Borzilleri, K.A., Withka, J.M., and Palmer, A.G., III. (1999).
Compensating for variations in 1H13C scalar coupling constants in isotope-
filtered NMR experiments. J. Am. Chem. Soc. 121, 5346–5347.
Unterreitmeier, S., Fuchs, A., Scha¨ffler, T., Heym, R.G., Frishman, D., and
Langosch, D. (2007). Phenylalanine promotes interaction of transmembrane
domains via GxxxG motifs. J. Mol. Biol. 374, 705–718.
Volynsky, P.E., Polyansky, A.A., Fakhrutdinova, G.N., Bocharov, E.V., and
Efremov, R.G. (2013). Role of dimerization efficiency of transmembrane
domains in activation of fibroblast growth factor receptor 3. J. Am. Chem.
Soc. 135, 8105–8108.
Wagner, G., DeMarco, A., and Wu¨thrich, K. (1976). Dynamics of the aromatic
amino acid residues in the globular conformation of the basic pancreatic
trypsin inhibitor (BPTI). I. 1H NMR studies. Biophys. Struct. Mech. 2, 139–158.93, November 5, 2013 ª2013 Elsevier Ltd All rights reserved 2093
